EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimized Epitope-Flanking Sequences Enhance Antigen Presentation and T-Cell Responses Following mRNA Vaccination

Marie-Pierre Hardy iD, Gabriel Ouellet-Lavallée, Catherine Thériault, Chantal Durette iD, Krystel Vincent, Robin Minati iD, Isabelle Caron, Assya Trofimov iD, Joel Lanoix iD, Jean-Philippe Laverdure iD, Pierre Thibault iD, Claude Perreault iD

Cells · 2026

DOI: 10.3390/cells15191753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Marie-Pierre Hardy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada. Hauptthemen laut MEDLINE: Antigen Presentation, CD8-Positive T-Lymphocytes, RNA, Messenger, Vaccination. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioCanRx, Epitopea Inc., BioCanRx/Ovarian Cancer Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA vaccines can encode multiple tumor antigens whose presentation ultimately depends on adequate intracellular processing. To evaluate the potential impact of epitope-flanking sequences, we compared the immunogenicity of two mRNA vaccines in the MC38 mouse model. Both vaccines coded for the same tumor-specific antigens (TSAs). The only difference between the two vaccines was the identity of the epitope-flanking amino acids. The vaccine encoding TSAs bordered by optimized flanking sequences (TSA-Opti) cleared established tumors and elicited robust CD8+ T-cell responses. In contrast, the vaccine encoding the same TSAs surrounded by natural flanking sequences (TSA-Nat) induced weaker responses and incomplete protection against tumor growth. Quantitative immunopeptidomics showed that TSA-Opti increased antigen presentation levels, providing a mechanistic link between flanking-sequence design and the enhanced magnitude, clonal diversity, and functionality of TSA-specific CD8+ T cells. TSA-Opti further promoted durable memory, conferring long-term protection against tumor rechallenge. These results identify epitope-flanking sequences as tunable design elements that control peptide–MHC I density and thereby shape the magnitude, clonal diversity, tissue localization, and durability of antitumor CD8+ T-cell immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigen PresentationCD8-Positive T-LymphocytesRNA, MessengerVaccinationCancer VaccinesEpitopesEpitopes, T-LymphocytemRNA VaccinesAnimalsMiceMice, Inbred C57BLAntigens, NeoplasmFemale

Stichwörter der Autor:innen

CD8+ T cellsMHC-I antigen presentationcancer immunotherapyepitope-flanking sequencesimmunopeptidomicsmRNA vaccinemulti-epitope vaccinetumor-specific antigen

Substanzen

RNA, MessengerCancer VaccinesEpitopesEpitopes, T-LymphocyteAntigens, NeoplasmmRNA Vaccines

Autor:innen und Institutionen

  • Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada.
  • Epitopea, Inc., Montréal, QC H3T 1J4, Canada.
  • Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC H1T 2M4, Canada.
  • Cognate Biotechnology Research, Montréal, QC H2S 3H1, Canada.
  • Department of Chemistry, Université de Montréal, Montréal, QC H2V 0B3, Canada.
  • Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada.

ORCID-Profile: Marie-Pierre Hardy, Chantal Durette, Robin Minati, Assya Trofimov, Joel Lanoix, Jean-Philippe Laverdure, Pierre Thibault, Claude Perreault

Förderung

  • BioCanRx
  • Epitopea Inc.
  • BioCanRx/Ovarian Cancer Canada
  • Katelyn Bedard Bone Marrow Association

Zitieren

APA

Hardy, M. P., Ouellet-Lavallée, G., Thériault, C., Durette, C., Vincent, K., Minati, R., Caron, I., Trofimov, A., Lanoix, J., Laverdure, J. P., Thibault, P., & Perreault, C. (2026). Optimized Epitope-Flanking Sequences Enhance Antigen Presentation and T-Cell Responses Following mRNA Vaccination. Cells. https://doi.org/10.3390/cells15191753

Vancouver

Hardy MP, Ouellet-Lavallée G, Thériault C, Durette C, Vincent K, Minati R, et al. Optimized Epitope-Flanking Sequences Enhance Antigen Presentation and T-Cell Responses Following mRNA Vaccination. Cells. 2026. doi:10.3390/cells15191753

BibTeX
@article{Hardy2026,
  author = {Hardy, Marie-Pierre and Ouellet-Lavallée, Gabriel and Thériault, Catherine and Durette, Chantal and Vincent, Krystel and Minati, Robin and Caron, Isabelle and Trofimov, Assya and Lanoix, Joel and Laverdure, Jean-Philippe and Thibault, Pierre and Perreault, Claude},
  title = {Optimized Epitope-Flanking Sequences Enhance Antigen Presentation and T-Cell Responses Following mRNA Vaccination},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15191753}
}
Kostenlos starten →